|
Volumn 26, Issue 5 SUPPL. 16, 1999, Pages 24-26
|
Phase II trials of vinorelbine and docetaxel in the treatment of advanced non-small cell lung cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOCETAXEL;
NAVELBINE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ADVANCED CANCER;
ARTICLE;
CANCER SURVIVAL;
CLINICAL TRIAL;
DISEASE SEVERITY;
DOSE RESPONSE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LACRIMATION;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
META ANALYSIS;
MUCOSA INFLAMMATION;
NEUTROPENIA;
ONYCHOLYSIS;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS, PHASE II;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
SURVIVAL ANALYSIS;
TAXOIDS;
VINBLASTINE;
|
EID: 0032722640
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (11)
|